ALZA

ALZA Corporation

ALZA Corporation was an influential pharmaceutical and medical systems company focused on drug delivery systems. Founded in 1968, the company was instrumental in pioneering numerous technologies that control drug delivery to enhance therapeutic benefits.

Error creating thumbnail:

ALZA plaza

Overview

ALZA's primary objective was to devise novel methods for administering drugs more efficiently, safely, and conveniently. By improving drug delivery, the company aimed to optimize therapeutic effects while minimizing side effects.

History

• 1968: Dr. Alejandro Zaffaroni founded ALZA in Palo Alto, California. The name "ALZA" was derived from Zaffaroni's name.
• 1990s: ALZA introduced several breakthrough products based on its unique drug delivery technologies.
• 2001: Johnson & Johnson, a multinational medical and pharmaceutical conglomerate, acquired ALZA in a deal that was aimed at strengthening its drug delivery capabilities.

Key Innovations and Products

• Transdermal patches: ALZA was among the pioneers in developing patches that release drugs through the skin, such as the nicotine patch for smoking cessation.
• Oral drug delivery systems: ALZA developed the OROS (osmotic controlled-release oral delivery system) which provides steady medication release over an extended period.
• Implantable drug delivery: Devices designed to release drugs at a steady rate for prolonged periods, often implanted subcutaneously.

Research and Development

Throughout its existence, ALZA remained at the forefront of innovation in drug delivery systems. The company's R&D department worked closely with clinical researchers, scientists, and doctors to innovate and improve upon existing drug delivery methodologies.

Collaborations and Partnerships

ALZA formed strategic alliances with several pharmaceutical companies to apply its drug delivery technologies to their medications, thereby enhancing the therapeutic profiles of established drugs.

Facilities

ALZA had state-of-the-art research, manufacturing, and administrative facilities in California, ensuring that they maintained the highest standards of quality and innovation in their products.

Legacy

Even after its acquisition by Johnson & Johnson, the legacy of ALZA's innovations continued to influence the field of drug delivery. Many of its technologies are still widely used, and the company's emphasis on improving patient outcomes remains a benchmark in the industry.

See Also

• Drug delivery
• Pharmaceutical industry
• Transdermal patch
• Johnson & Johnson
• Therapeutics

References

• [1] "ALZA's Innovations in Drug Delivery". PharmaTech Journal.
• [2] "From Startup to Pharma Giant: The ALZA Story". Silicon Valley Historical Association.
• [3] "Johnson & Johnson and ALZA: A Drug Delivery Dynamo". BusinessWeek Magazine.

External Links

• [ALZA's Historical Overview - Johnson & Johnson Archives]
• [ALZA Drug Delivery Innovations - Medical News Today]

This article is a stub. You can help WikiMD by registering to expand it. Editing is available only to registered and verified users. WikiMD is a comprehensive, free health & wellness encyclopedia.